Nrf2 is a novel regulator of bone acquisition

Bone

Volumn 63, Issue , 2014, Pages 36-46

  Park, Cheol Kyu ^a   Lee, Youngkyun ^b   Kim, Kyun Ha ^c   Lee, Zang Hee ^a   Joo, Myungsoo ^c   Kim, Hong Hee ^a  

^a Seoul National University   (South Korea)

^b Kyungpook National University   (South Korea)

^c Pusan National University   (South Korea)

Author keywords

NF B; NFATc1; Nrf2; OPG; Osteoblast; Osteoclast

Indexed keywords

DEOXYPYRIDINOLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCALCIN; PROTEIN C FOS; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC1; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; OSTEOPROTEGERIN; PROTEIN BINDING;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE METABOLISM; BONE MINERALIZATION; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; UPREGULATION; ANIMAL; BONE DEVELOPMENT; C57BL MOUSE; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; CHROMATIN IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NFATC TRANSCRIPTION FACTORS; OSTEOBLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; PROTEIN BINDING;

EID: 84896048226     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2014.01.025     Document Type: Article

References (35)

1. Franceschi R.T. The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment. Crit Rev Oral Biol Med 1999, 10:40-57.
2. Lawson A.C., Czernuszka J.T. Collagen-calcium phosphate composites. Proc Inst Mech Eng H 1998, 212:413-425.
3. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
4. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
5. Vaananen H.K., Zhao H., Mulari M., Halleen J.M. The cell biology of osteoclast function. J Cell Sci 2000, 113(Pt 3):377-381.
6. Boyce B.F., Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008, 473:139-146.
7. Lee Z.H., Kim H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem Biophys Res Commun 2003, 305:211-214.
8. Asagiri M., Sato K., Usami T., Ochi S., Nishina H., Yoshida H., et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J Exp Med 2005, 202:1261-1269.
9. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., Bravo R. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 1997, 3:1285-1289.
10. Wauquier F., Leotoing L., Coxam V., Guicheux J., Wittrant Y. Oxidative stress in bone remodelling and disease. Trends Mol Med 2009, 15:468-477.
11. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 2011, 85:241-272.
12. Hayes J.D., McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci 2009, 34:176-188.
13. Dhakshinamoorthy S., Long D.J., Jaiswal A.K. Antioxidant regulation of genes encoding enzymes that detoxify xenobiotics and carcinogens. Curr Top Cell Regul 2000, 36:201-216.
14. Zhang D.D. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006, 38:769-789.
15. Kobayashi M., Yamamoto M. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul 2006, 46:113-140.
16. Copple I.M., Goldring C.E., Kitteringham N.R., Park B.K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 2008, 246:24-33.
17. Kobayashi A., Kang M.I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004, 24:7130-7139.
18. Hong F., Sekhar K.R., Freeman M.L., Liebler D.C. Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation. J Biol Chem 2005, 280:31768-31775.
19. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A 2002, 99:11908-11913.
20. Hinoi E., Fujimori S., Wang L., Hojo H., Uno K., Yoneda Y. Nrf2 negatively regulates osteoblast differentiation via interfering with Runx2-dependent transcriptional activation. J Biol Chem 2006, 281:18015-18024.
21. Lee S.E., Chung W.J., Kwak H.B., Chung C.H., Kwack K.B., Lee Z.H., et al. Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK. J Biol Chem 2001, 276:49343-49349.
22. Lee Y., Ha J., Kim H.J., Kim Y.S., Chang E.J., Song W.J., et al. Negative feedback Inhibition of NFATc1 by DYRK1A regulates bone homeostasis. J Biol Chem 2009, 284:33343-33351.
23. Chang E.J., Ha J., Oerlemans F., Lee Y.J., Lee S.W., Ryu J., et al. Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat Med 2008, 14:966-972.
24. Yamashita T., Yao Z., Li F., Zhang Q., Badell I.R., Schwarz E.M., et al. NF-kappaB p50 and p52 regulate receptor activator of NF-kappaB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J Biol Chem 2007, 282:18245-18253.
25. Takeda S., Yoshizawa T., Nagai Y., Yamato H., Fukumoto S., Sekine K., et al. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice. Endocrinology 1999, 140:1005-1008.
26. Miyaura C., Inada M., Matsumoto C., Ohshiba T., Uozumi N., Shimizu T., et al. An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med 2003, 197:1303-1310.
27. Ha J., Choi H.S., Lee Y., Lee Z.H., Kim H.H. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Int Immunopharmacol 2009, 9:774-780.
28. Hyeon S., Lee H., Yang Y., Jeong W. Nrf2 deficiency induces oxidative stress and promotes RANKL-induced osteoclast differentiation. Free Radic Biol Med 2013, 65:789-799.
29. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002, 3:889-901.
30. Thimmulappa R.K., Lee H., Rangasamy T., Reddy S.P., Yamamoto M., Kensler T.W., et al. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest 2006, 116:984-995.
31. Gerritsen M.E., Williams A.J., Neish A.S., Moore S., Shi Y., Collins T. CREB-binding protein/p300 are transcriptional coactivators of p65. Proc Natl Acad Sci U S A 1997, 94:2927-2932.
32. Ashburner B.P., Westerheide S.D., Baldwin A.S. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 2001, 21:7065-7077.
33. Thangasamy A., Rogge J., Krishnegowda N.K., Freeman J.W., Ammanamanchi S. Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion. J Biol Chem 2011, 286:32115-32122.
34. Jansen T., Hortmann M., Oelze M., Opitz B., Steven S., Schell R., et al. Conversion of biliverdin to bilirubin by biliverdin reductase contributes to endothelial cell protection by heme oxygenase-1-evidence for direct and indirect antioxidant actions of bilirubin. J Mol Cell Cardiol 2010, 49:186-195.
35. Zwerina J., Tzima S., Hayer S., Redlich K., Hoffmann O., Hanslik-Schnabel B., et al. Heme oxygenase 1 (HO-1) regulates osteoclastogenesis and bone resorption. FASEB J 2005, 19:2011-2013.